Literature DB >> 19522661

Topological transformation of liposomes by a membrane-affecting domain of recombinant human erythropoietin.

Stefanie Strobach1, Renate Kunert, Johannes Stadlmann, Paul Messner, Eva Sevcsik, Gabriele Lhota, Hermann Katinger, Karola Vorauer-Uhl.   

Abstract

Recombinant human erythropoietin (rh-Epo) is well accepted as a hematopoietic drug, but many other pleiotropic properties are currently under investigation. Rh-Epo-induced receptor-mediated signal transductions are accompanied with membrane dynamic processes, which facilitate the activation of individual pathways. However, its direct effect on membrane dynamics is still unknown. In the present study, we have proven the capability of rh-Epo to associate to and transform artificial lipid membranes. Association studies using neutral, negatively, and positively charged liposomes with the native as well as modified rh-Epo were performed and analyzed by transmission electron microscopy and differential scanning calorimetry. By these studies, we demonstrated that rh-Epo has the capability to transform negatively charged unilamellar vesicles into so-called disc-like micelles. Rh-Epo association to the negatively charged head groups via lysine and arginine initiates this transformation. At physiological temperatures, conformational changes within the rh-Epo structure expose a defined amino-acid sequence, which is able to induce the formation of discoid membrane structures. Enzymatic digestion, analysis, and isolation of related peptides by rp-HPLC and characterization by MS/MS enabled the identification of the membrane-affecting domain of rh-Epo (MAD-E) that represents the exposed helix B of rh-Epo. Finally, association studies performed with these peptides confirmed that the MAD-E is responsible for the formation of disc-like micelles. Since this helix B of rh-Epo has recently been supposed to be involved in the activation of neuroprotective pathways, we believe that the membrane-transforming capacity of rh-Epo participates in the proliferative activity of rh-Epo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19522661      PMCID: PMC4388395          DOI: 10.3109/08982100903015033

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  43 in total

Review 1.  Erythropoietin after a century of research: younger than ever.

Authors:  Wolfgang Jelkmann
Journal:  Eur J Haematol       Date:  2007-01-23       Impact factor: 2.997

2.  Mapping of the active site of recombinant human erythropoietin.

Authors:  S Elliott; T Lorenzini; D Chang; J Barzilay; E Delorme
Journal:  Blood       Date:  1997-01-15       Impact factor: 22.113

Review 3.  Effects of erythropoietin on brain function.

Authors:  W Jelkmann
Journal:  Curr Pharm Biotechnol       Date:  2005-02       Impact factor: 2.837

Review 4.  Enzymes inside lipid vesicles: preparation, reactivity and applications.

Authors:  P Walde; S Ichikawa
Journal:  Biomol Eng       Date:  2001-10-31

5.  Kinetic stabilization and fusion of apolipoprotein A-2:DMPC disks: comparison with apoA-1 and apoC-1.

Authors:  Shobini Jayaraman; Donald L Gantz; Olga Gursky
Journal:  Biophys J       Date:  2005-01-28       Impact factor: 4.033

6.  Complex of human apolipoprotein C-1 with phospholipid: thermodynamic or kinetic stability?

Authors:  Olga Gursky; Donald L Gantz
Journal:  Biochemistry       Date:  2002-06-11       Impact factor: 3.162

7.  Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.

Authors:  Michael Brines; Giovanni Grasso; Fabio Fiordaliso; Alessandra Sfacteria; Pietro Ghezzi; Maddalena Fratelli; Roberto Latini; Qiao-Wen Xie; John Smart; Chiao-Ju Su-Rick; Eileen Pobre; Deborah Diaz; Daniel Gomez; Carla Hand; Thomas Coleman; Anthony Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-29       Impact factor: 11.205

Review 8.  The role of erythropoietin in central and peripheral nerve injury.

Authors:  Marios G Lykissas; Anastasios V Korompilias; Marios D Vekris; Grigorios I Mitsionis; Ekaterini Sakellariou; Alexandros E Beris
Journal:  Clin Neurol Neurosurg       Date:  2007-07-12       Impact factor: 1.876

9.  A sequential dimerization mechanism for erythropoietin receptor activation.

Authors:  D J Matthews; R S Topping; R T Cass; L B Giebel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

10.  Interaction of LL-37 with model membrane systems of different complexity: influence of the lipid matrix.

Authors:  E Sevcsik; G Pabst; W Richter; S Danner; H Amenitsch; K Lohner
Journal:  Biophys J       Date:  2008-03-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.